[Treatment of a positive Rhesus D neonate born of a mother with idiopathic thrombopenic purpura with anti-D immunoglobulins (Rh O)].
A Rhesus D positive infant, born at 37 weeks of gestational age, admitted for neonatal passive immune thrombocytopenia was given 3 intravenous anti-Rhesus D immunoglobulin infusions at 3 weeks of age. This thrombocytopenia which had not responded to conventional therapy improved after the third of anti-Rhesus D immunoglobulin infusion, but the efficacy of this treatment could not be proven in this case report. However, the tolerance was good. No side-effects (jaundice, severe anemia) were observed.
di Maria
H
H
Service de Néonatologie, Hôpital Tenon, Paris.
Parnet Mathieu
F
F
Rio di Maria
D
D
Maigret
P
P
Gire
R
R
Guillot
F
F
Lasfargues
G
G
Brossard
Y
Y
D004899:Erythroblastosis, Fetal / Q000276:immunology* / Q000628:therapy; D005260:Female; D005865:Gestational Age; D006801:Humans; D007136:Immunoglobulins / Q000008:administration & dosage*; D007231:Infant, Newborn; D010477:Perfusion; D011247:Pregnancy; D011248:Pregnancy Complications / Q000276:immunology*; D012204:Rh-Hr Blood-Group System / Q000276:immunology*; D018029:Rho(D) Immune Globulin; D013921:Thrombocytopenia / Q000235:genetics / Q000628:therapy*
D007136:Immunoglobulins; D012204:Rh-Hr Blood-Group System; D018029:Rho(D) Immune Globulin
Traitement d'un nouveau-né Rhésus D positif né de mère atteinte d'un purpura thrombopénique idiopathique par immunoglobulines anti-D (Rh O).